CAS No.: 849643-15-8
SU14813 maleate Catalog No. CSN15795
SU14813 maleate is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), Kit, and fms-like tyrosine kinase 3 (FLT-3).
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 参考文献
- [1] Hu-Lowe D, Brega N, et al. The discovery and development of SU14813, a next-generation multitargeted tyrosine kinase inhibitor for the treatment of human malignancies. Mol Cancer Ther. 2011 Nov;10(11):2015.
- [2] Patyna S, Laird AD, et al. SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity. Mol Cancer Ther. 2006 Jul;5(7):1774-82.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 849643-15-8 | 储存条件 |
|
|
| 分子式 | C27H31FN4O8 | 运输 | 蓝冰 | |
| 分子量 | 558.56 | 别名 |
